心臟结构器材市场规模、份额、成长分析、按产品、按程序、按地区 - 产业预测，2024-2031 年

Structural Heart Devices Market Size, Share, Growth Analysis, By Product, By Procedure, By Region - Industry Forecast 2024-2031

出版日期: 2024年10月03日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年心臟结构器材市场规模将为109.7亿美元，从2023年的119.7亿美元成长到2031年的245.8亿美元，预测期间（2024-2031年）复合年增长率为9.4%

全球结构性心臟器械市场在几个关键因素的推动下出现强劲增长，包括结构性心臟病发病率上升、微创手术技术的进步以及人口老化的扩大。随着心血管疾病盛行率的增加，对心臟结构装置的需求只会持续增加，进一步推动创新治疗方案的采用。该市场得到了对技术先进设备的大力推动以及对研发的大量投资的支持，凸显了该领域创新的重要性。然而，这些设备的高成本和严格的监管障碍等挑战可能会阻碍成长。儘管存在这些障碍，但在心臟结构治疗设备技术的持续进步以及对以患者为中心的循环系统医学护理日益浓厚的兴趣的支持下，市场预计将保持上升势头。特别是，美国心臟结构器材市场预计将持续成长，预计在预测期内将保持稳定的年复合成长率（CAGR）。这一趋势凸显了医疗保健产业致力于透过增强结构性心臟病领域的治疗选择和最尖端科技解决方案来改善患者的治疗结果。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市集活动
主要企业市场占有率（2023年）

主要企业简介

Boston Scientific Corporation
Medtronic
Edwards Lifesciences Corporation
Abbott Laboratories
Biomerics
Teleflex Incorporated
LivaNova PLC
JenaValve Technology, Inc.
CardioKinetix
Lepu Medical Technology
CryoLife
Micro Interventional Devices
Braile Biomedica
TTK Healthcare（A TTK Group Company）

简介目录

Product Code: SQMIG35G2184

Structural Heart Devices Market size was valued at USD 10.97 billion in 2022 and is poised to grow from USD 11.97 billion in 2023 to USD 24.58 billion by 2031, growing at a CAGR of 9.4% in the forecast period (2024-2031)

The global structural heart devices market is experiencing robust growth, fueled by several key factors, including the rising incidence of structural heart diseases, advancements in minimally invasive surgical techniques, and an expanding aging demographic. As the prevalence of cardiovascular conditions escalates, the demand for structural heart devices continues to increase, further driving the adoption of innovative treatment options. The market is bolstered by a strong push for technologically advanced devices and significant investments in research and development, highlighting the importance of innovation in this sector. However, challenges such as the high costs of these devices and strict regulatory hurdles could hinder growth. Despite these obstacles, the market is anticipated to maintain its upward trajectory, supported by continuous advancements in structural heart device technology and a heightened focus on patient-centered care within cardiology. In particular, the U.S. structural heart devices market is well-positioned for sustainable growth, with expectations for a steady compound annual growth rate (CAGR) in the upcoming forecast period. This trend underscores the healthcare industry's commitment to improving patient outcomes through enhanced treatment options and cutting-edge technological solutions in the realm of structural heart diseases.

Top-down and bottom-up approaches were used to estimate and validate the size of the Structural Heart Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Structural Heart Devices Market Segmental Analysis

Global Structural Heart Devices Market is segmented by Product, Procedure, and region. Based on Product, the market is segmented into Heart Valve Devices (Transcatheter Heart Valves, Surgical Heart Valves (Tissue Heart Valves, Mechanical Heart Valves)), Occluders & Delivery Systems, Annuloplasty Rings, Accessories, and Other Devices. Based on Procedure, the market is segmented into Replacement Procedures (TAVR Procedures, Savr Procedures), Repair Procedures (Closure Procedures, Annuloplasty, Valvuloplasty, TMVR Procedures). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Structural Heart Devices Market

The global structural heart devices market is significantly driven by the rising prevalence of structural heart diseases, including heart valve disorders and congenital abnormalities, which necessitate advanced treatment options. As the incidence of these conditions escalates, the demand for specialized devices has surged. Furthermore, technological advancements in minimally invasive procedures have enhanced patient outcomes, making treatments more accessible and effective. Coupled with the increasing geriatric population, which is particularly vulnerable to these ailments, the market continues to expand. This growing demographic shift and innovation in medical devices create a robust environment for the structural heart devices market's growth and evolution.

Restraints in the Structural Heart Devices Market

The global structural heart devices market faces a significant restraint due to the high costs associated with these advanced medical devices and their implantation procedures. The expense encompasses not only the devices themselves but also the comprehensive costs of development, clinical trials, and adherence to regulatory standards, which can place a financial strain on both patients and healthcare systems. In particular, developing regions may experience limited accessibility and affordability, further curtailing market penetration. Additionally, price sensitivity among consumers and restricted insurance coverage in certain markets can impede the widespread adoption of structural heart devices, ultimately stunting the overall growth of the market.

Market Trends of the Structural Heart Devices Market

A prominent trend in the global structural heart devices market is the surge in minimally invasive procedures, exemplified by transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve repair (TMVR). These innovative techniques are increasingly favored for their substantial advantages, including shorter hospital stays, expedited recovery times, and diminished complications compared to conventional open-heart surgeries. This growth is propelled by continuous advancements in medical technology that enhance procedural precision and efficacy. As healthcare providers and patients alike recognize the benefits of these less invasive options, the demand for structural heart devices is expected to rise steadily, shaping the market's future landscape.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Regulatory Analysis
Case Study Analysis
Market Attractiveness Index
Supply Chain Analysis
Customer & Buying Criteria Analysis

Structural Heart Devices Market, By Product

Market Overview
Heart Valve Devices
- Transcatheter Heart Valves
- Surgical Heart Valves
- Tissue Heart Valves
- Mechanical Heart Valves
Occluders & Delivery Systems
Annuloplasty Rings
Accessories
Other Devices

Structural Heart Devices Market, By Procedure

Replacement Procedures
Tavr Procedures
Savr Procedures
Repair Procedures
Closure Procedures
Annuloplasty
Valvuloplasty
Tmvr Procedures

Structural Heart Devices Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Boston Scientific Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Edwards Lifesciences Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biomerics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teleflex Incorporated
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LivaNova PLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
JenaValve Technology, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CardioKinetix
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lepu Medical Technology
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CryoLife
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Micro Interventional Devices
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Braile Biomedica
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TTK Healthcare (A TTK Group Company)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments